Australia's Potential Rescheduling of MDMA &…

Mind Medicine Australia Submits Application for MDMA and Psilocybin Rescheduling In the same week that COMPASS announced IPO plans and Esketamine was again rejected by England’s National Health Services because of the price tag it is only fitting that Mind Medicine Australia is petitioning the Australian Therapeutic Goods Administration (TGA) to circumvent the traditional drug development process and

Read →